死亡之谷:为什么澳大利亚未能在COVID-19中开发出临床有效的药物
1Clinical Pharmacology and Drug Repurposing and Medicines Research Program, University of Newcastle, Newcastle, New South Wales, Australia.
Internal medicine journal
|December 5, 2023
概括
对COVID-19药物试验和疫苗开发的公共支出缺乏透明度和价值评估. 解决认知偏见和整合临床药理学专业知识可以改善澳大利亚.
科学领域:
- 药理学和临床治疗学
- 公共卫生政策 公共卫生政策
- 流行病的准备情况 流行病的准备情况
背景情况:
- 在COVID-19大流行期间,关于药物试验的成本效益的有限公共话语.
- 对疫苗和药物研究的重大公共投资没有为澳大利亚带来任何可交付的药物或疫苗.
- 由于国内治疗开发不足,澳大利亚依赖全球供应链和商业定价.
研究的目的:
- 在COVID-19大流行期间分析药物试验的价值和公共成本.
- 在澳大利亚的治疗发展战略中识别认知偏见和系统性失败.
- 为应对未来流行病的国家治疗和临床试验战略提出改进建议.
主要方法:
- 在COVID-19大流行期间,对药物试验和疫苗开发的公共支出进行审查.
- 对潜在影响治疗发展决策的认知偏见的分析.
- 评估临床药理学专业知识在领导和战略中的作用.
主要成果:
- 缺乏关于COVID-19药物试验成本和价值的透明度.
- 识别认知偏见,包括低估发展复杂性和缺乏系统思维.
- 关键决策团队中缺乏临床药理学和翻译科学专业知识.
结论:
- 解决认知偏见和整合临床药理学对于有效的治疗开发至关重要.
- 澳大利亚需要一个强大的治疗和临床试验的国家战略,与疾病控制中心集成.
- 改进的战略对于加强国家准备和减少对未来流行病的外部因素的依赖至关重要.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.9K
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.0K
相关概念视频
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Administration and Therapy Phases: Overview
476
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
476
Pharmacovigilance
850
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850
